The effect of Moving On, a self management program for people with a chronic illness, on participants' self management knowledge, self efficacy and lifestyle behaviours.

Not Applicable

Completed

• Conditions: Coronary Heart Disease, Diabetes, Respiratory Illnesses, Asthma.; Cardiovascular - Coronary heart disease; Metabolic and Endocrine - Diabetes; Respiratory - Asthma

• Registration Number: ACTRN12609000298213
• Lead Sponsor: niversity of New South wales

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-05-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Consumers are eligible to join the study if (1) they are aged between 45-75yrs; (2) were not recently diagnosed with a chronic illness (provider determined); (3) have a reasonable understanding of their chronic ilness (provider determined); (4)are able to speak, write and understand english (provider determined); (5)agree to attend group education sessions (provider determined).

Exclusion Criteria

Consumers are not eligible to join the study if (1) they have been diagnosed with a severe mental illness (excluding depression and anxiety); (2) they have cognitive impairment issues including dementia; (3)they have substance abuse issues; (4) they are unable to participate in light physical activity.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in self efficacy (Stanford Self Efficacy for Managing Chronic Disease 6 Item Scale)[Measured at baseline and 4 months follow up];Change in self management knowledge and behaviour (Scales developed & previously piloted for the specific purposes of the trial)[Measured at baseline and 4 months follow up];Improvement in perceived health status (Stanford Self Rated Health Scale)[Measured at baseline and 4 months follow up]

Secondary Outcome Measures

Name	Time	Method
Improvement in work and social adjustment scores (Work and Social Adjustment Scale)[Measured at baseline and 4 months follow up];Greater knowledge concerning use of medicines (Scale developed & previously piloted for the specific purposes of the trial)[Measured at baseline and 4 months follow up];Improvement in anxiety and depression scores (Hospital Anxiety and Depression Scale)[Measured at baseline and 4 months follow up]